Articles related to ‘Dermatology’
-
Ustekinumab for plaque psoriasis approved by FDA
-
Efalizumab (Raptiva) for plaque psoriasis. EMEA recommends withdrawal of its marketing authorization, FDA issues public health advisory
-
Potential new indication of beta blockers: improve wound healing
-
Review of retapamulin (Altargo), a new topical antibiotic for skin infections
-
Efalizumab (Raptiva) and progressive multifocal leukoencephalopathy (PML). New safety information
